Patent · US Active

Inhibitors of beta-secretase

US9212153B2 · kind B2 · utility

1Cited by

7References

23Claims

0Family size

Assignees

Vitae Pharmaceuticals, LLC · US
Boehringer Ingelheim International GmbH · DE

Inventors

Salvacion Cacatian · Conshohocken, US
David A. Claremon · Audubon, US
Lawrence Wayne Dillard · Yardley, US
Klaus Fuchs · Ingelheim am Rhein, DE
Niklas Heine · Eberhardzell, DE
Lanqi Jia · Horsham, US
Katerina Leftheris · Skillman, US
Brian McKeever · Lake Ronkonkoma, US
Angel Morales-Ramos · Blue Bell, US
Suresh B. Singh · Kendall Park, US
Shankar Venkatraman · Lansdale, US
Guosheng Wu · Beijing, CN
Zhongren Wu · Zhuhai, CN
Zhenrong Xu · Forest Park, US
Jing Yuan · Lansdale, US
Yajun Zheng · Hockessin, US

Key dates

Filing date	Dec 18, 2013
Grant date	Dec 15, 2015
Priority date	—
Expiry date	Dec 18, 2033

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D513/10
WIPO fieldOrganic fine chemistry
WIPO sectorChemistry

Abstract

The present invention is directed to a compound represented by the following structural formulaor a pharmaceutically acceptable salt thereof. Pharmaceutical compositions and method of use of the compounds are also described.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.